Multiparametric MRI helps identify low- and high-grade brain gliomas, reducing risk of inappropriate or delayed surgery.
Multiparametric MR imaging significantly improved discrimination between low- and high-grade brain gliomas, according to a study published in the journal Radiology.
Researchers from Italy undertook a retrospective study to determine how multiparametric MR imaging, taking into account the heterogeneity of the lesions at MR imaging, affected current radiologic reporting methods and grading of brain gliomas.
A total of 118 patients with histologically confirmed brain gliomas were evaluated. The patients had undergone conventional and advanced MR sequences (perfusion-weighted imaging, MR spectroscopy, and diffusion-tensor imaging). Three evaluations were conducted:
The researchers found that there were significant differences in age, relative cerebral blood volume (rCBV) in contrast-enhanced regions (area under the ROC curve [AUC] = 0.937), areas of lowest signal intensity on T2-weighted images, restricted diffusivity regions, and choline/creatine ratio in regions with the lowest signal intensity on T2-weighted images.
“[Discriminant function analysis] (DFA) that included age; rCBV in contrast-enhanced regions, areas of lowest signal intensity on T2-weighted images, and areas of restricted diffusivity; and choline/creatine ratio in areas with lowest signal intensity on T2-weighted images was used to classify 95 percent of patients correctly,” the authors wrote. “Quantitative analysis showed a higher concordance with histologic findings than qualitative and semiquantitative methods (P < .0001).”
The researchers concluded that quantitative multiparametric MR imaging evaluation incorporating heterogeneity at MR imaging significantly improved discrimination between low- and high-grade brain gliomas with a very high AUC. This reduced the risk of inappropriate or delayed surgery.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.